Your browser doesn't support javascript.
loading
Healthy lifestyle, metabolomics and incident type 2 diabetes in a population-based cohort from Spain.
Delgado-Velandia, Mario; Gonzalez-Marrachelli, Vannina; Domingo-Relloso, Arce; Galvez-Fernandez, Marta; Grau-Perez, Maria; Olmedo, Pablo; Galan, Iñaki; Rodriguez-Artalejo, Fernando; Amigo, Nuria; Briongos-Figuero, Laisa; Redon, Josep; Martin-Escudero, Juan Carlos; Monleon-Salvado, Daniel; Tellez-Plaza, Maria; Sotos-Prieto, Mercedes.
Afiliação
  • Delgado-Velandia M; Department of Preventive Medicine and Public Health. School of Medicine, Universidad Autonoma de Madrid; Instituto de Investigacion Sanitaria Hospital Universitario La Paz (IdiPaz), Madrid, Spain.
  • Gonzalez-Marrachelli V; Department of Physiology, School of Medicine, University of Valencia, Valencia, Spain.
  • Domingo-Relloso A; Institute for Biomedical Research Hospital Clinic de Valencia INCLIVA, Valencia, Spain.
  • Galvez-Fernandez M; Integrative Epidemiology Group, Department of Chronic Diseases Epidemiology, National Center for Epidemiology, Carlos III Health Institutes, Madrid, Spain.
  • Grau-Perez M; Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, NY, USA.
  • Olmedo P; Department of Statistics and Operations Research, University of Valencia, Valencia, Spain.
  • Galan I; Department of Preventive Medicine and Public Health. School of Medicine, Universidad Autonoma de Madrid; Instituto de Investigacion Sanitaria Hospital Universitario La Paz (IdiPaz), Madrid, Spain.
  • Rodriguez-Artalejo F; Integrative Epidemiology Group, Department of Chronic Diseases Epidemiology, National Center for Epidemiology, Carlos III Health Institutes, Madrid, Spain.
  • Amigo N; Department of Preventive Medicine and Public Health. School of Medicine, Universidad Autonoma de Madrid; Instituto de Investigacion Sanitaria Hospital Universitario La Paz (IdiPaz), Madrid, Spain.
  • Briongos-Figuero L; Institute for Biomedical Research Hospital Clinic de Valencia INCLIVA, Valencia, Spain.
  • Redon J; Department of Statistics and Operations Research, University of Valencia, Valencia, Spain.
  • Martin-Escudero JC; Institute for Biomedical Research Hospital Clinic de Valencia INCLIVA, Valencia, Spain.
  • Monleon-Salvado D; Department of Legal Medicine and Toxicology. School of Medicine, University of Granada, Granada, Spain.
  • Tellez-Plaza M; Department of Preventive Medicine and Public Health. School of Medicine, Universidad Autonoma de Madrid; Instituto de Investigacion Sanitaria Hospital Universitario La Paz (IdiPaz), Madrid, Spain.
  • Sotos-Prieto M; Department of Chronic Diseases Epidemiology, National Center for Epidemiology, Carlos III Health Institute, Monforte de Lemos, 5, 28029, Madrid, Spain.
Int J Behav Nutr Phys Act ; 19(1): 8, 2022 01 27.
Article em En | MEDLINE | ID: mdl-35086546
ABSTRACT

BACKGROUND:

The contribution of metabolomic factors to the association of healthy lifestyle with type 2 diabetes risk is unknown. We assessed the association of a composite measure of lifestyle with plasma metabolite profiles and incident type 2 diabetes, and whether relevant metabolites can explain the prospective association between healthy lifestyle and incident type 2 diabetes.

METHODS:

A Healthy Lifestyle Score (HLS) (5-point scale including diet, physical activity, smoking status, alcohol consumption and BMI) was estimated in 1016 Hortega Study participants, who had targeted plasma metabolomic determinations at baseline examination in 2001-2003, and were followed-up to 2015 to ascertain incident type 2 diabetes.

RESULTS:

The HLS was cross-sectionally associated with 32 (out of 49) plasma metabolites (2.5% false discovery rate). In the subset of 830 participants without prevalent type 2 diabetes, the rate ratio (RR) and rate difference (RD) of incident type 2 diabetes (n cases = 51) per one-point increase in HLS was, respectively, 0.69 (95% CI, 0.51, 0.93), and - 8.23 (95% CI, - 16.34, - 0.13)/10,000 person-years. In single-metabolite models, most of the HLS-related metabolites were prospectively associated with incident type 2 diabetes. In probit Bayesian Kernel Machine Regression, these prospective associations were mostly driven by medium HDL particle concentration and phenylpropionate, followed by small LDL particle concentration, which jointly accounted for ~ 50% of the HLS-related decrease in incident type 2 diabetes.

CONCLUSIONS:

The HLS showed a strong inverse association with incident type 2 diabetes, which was largely explained by plasma metabolites measured years before the clinical diagnosis.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 Idioma: En Ano de publicação: 2022 Tipo de documento: Article